The key factors to successful innovative product development include ease of use, reasonable cost, and better outcomes than from conventional approaches. With this principle as its mission, Premium Medical Technology's innovations will poise to overcome common challenges to broadly used Laparoscopic procedures.
Without question, Laparoscopic Surgery has revolutionized the practice of surgery. IData Research shows approximately 13 million Laparoscopic procedures are performed globally each year. Premium Medical Technology strives to continue that trajectory, to fill the unmet needs by advancing innovative applications that will impact on the quality of surgery and improve patient outcomes.
StarFin Device
StarFin Device is a single-use, sterile, dual-purpose surgical instrument that is intended to be used for laparoscopic access, creation of pneumoperitoneum via gas insufflation (as a Veress needle) and a device used for efficient closure of trocar site wounds after laparoscopic surgery.
StarFin combines two separate functions into one low cost, single unitary surgical instrument. Premium Medical Technology has received FDA 510(K) Clearance K231407 for StarFin Device.
LAPAROSCOPIC TROCARS AND VERESS NEEDLES AND
OTHER VARIOUS LAPAROSCOPIC INSTRUMENTS
August 2023
Received FDA 510(K) Clearance K231407 for StarFin Device.
June 2022
Filed Provisional Patent for Hemostatic Device.
February 2022
Design, develop, prototype device for Hemostatic use.
July 2021
King & Spalding filed PCT Application for Laparoscopic Devices.
June 2020
Initial patent application for Laparoscopic Devices.
Copyright © 2024 PREMIUM MEDICAL TECHNOLOGY LLC - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.